Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Short term Debt (2023 - 2025)

Bioharvest Sciences has reported Short term Debt over the past 3 years, most recently at $149000.0 for Q4 2025.

  • For Q4 2025, Short term Debt fell 96.18% year-over-year to $149000.0; the TTM value through Dec 2025 reached $149000.0, down 96.18%, while the annual FY2025 figure was $149000.0, 96.18% down from the prior year.
  • Short term Debt was $149000.0 for Q4 2025 at Bioharvest Sciences, down from $3.9 million in the prior quarter.
  • Across five years, Short term Debt topped out at $3.9 million in Q4 2024 and bottomed at $149000.0 in Q4 2025.
  • The 3-year median for Short term Debt is $526000.0 (2023), against an average of $1.5 million.
  • Year-over-year, Short term Debt skyrocketed 642.4% in 2024 and then tumbled 96.18% in 2025.
  • Over 3 years, Short term Debt stood at $526000.0 in 2023, then skyrocketed by 642.4% to $3.9 million in 2024, then tumbled by 96.18% to $149000.0 in 2025.
  • The last three reported values for Short term Debt were $149000.0 (Q4 2025), $3.9 million (Q4 2024), and $526000.0 (Q4 2023) per Business Quant data.